Search Results 61-70 of 16036 for Lymphangioleiomyomatosis

  1. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...

  2. Study to Validate the Use of a Lymphatic Imaging Protocol to Stage Disease Severity in Patients with Lymphedema - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. Participation ...

  4. AI enables early identification, intervention in debilitating lung disease - Mayo Clinic News Network

    This tool could alert a patient's primary care team of a probable IPF diagnosis based on comorbidities and risk scores. The tool should prompt earlier referral ...

  5. Vitiligo - Symptoms & causes - Mayo Clinic

    Learn more about this condition in which your skin loses pigment cells, resulting in very light or white patches on parts of the body.

  6. Airway Tumors Specialty Group - Overview - Mayo Clinic

    At Mayo Clinic, a team of specialists in interventional pulmonology and thoracic surgery specialize in treating complex airway tumors.

  7. Immunity and Fibrosis - Center for Biomedical Discovery - Mayo Clinic Research

    Center for Biomedical Discovery at Mayo Clinic: Immunity and fibrosis research on the immune system in disease and causes of fibrosis and cirrhosis.

  8. A Study to Evaluate Progenitor Cells for Patients with Degenerative Lung Disease - Mayo Clinic

    The purpose of this study is to use a patient's own cells to fabricate a recellularized scaffold to repopulate the lung and restore function that could offer a ...

  9. Gaucher disease - Symptoms and causes - Mayo Clinic

    An enzyme that breaks down certain fatty substances doesn't work properly in people with Gaucher disease. Enzyme replacement therapy often helps.

  10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...